Pharmacy

Announcements

Emergency Temporary Policies to Address Shortages of IV and Peritoneal Dialysis Solutions in Utah

To address the potential shortage of IV and peritoneal dialysis solutions due to Hurricane Helene, the Division of Professional Licensing in collaboration with the Utah Board of Pharmacy, issued the following policies.

Read the policies here.

NEW REPORTING REQUIREMENT | Healthcare Providers with a Third-Party Medical Records Service

On July 1, 2023, HB 312 was enacted which requires all healthcare providers who utilize the services of a third-party medical records company to report this information to the Division of Professional Licensing. To learn more about this requirement and how to report the information, please visit us at: Third-Party Medical Records Reporting Requirement

Elimination of DATA-Waiver Program

A DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder. For more information about the elimination of the DATA-Waiver requirement, please refer to this document: DOPL Notice of Elimination of DATA-Waiver Program

Electronic Prescriptions for Controlled Substances

Beginning January 1, 2022, Utah Code Annotated 58-37-22 requires that most* prescriptions issued for a controlled substance be transmitted electronically as an electronic prescription; however, you may apply for a limited extension by submitting the form linked below.

Electronic Prescriptions for Controlled Substances: Request for Limited Extension to Comply

^{*FOR INFORMATION ON EXEMPTIONS, PLEASE SEE UTAH CODE ANNOTATED 58-37-22.}

While a prescriber is permitted to use any vendor, the Division* is aware of the vendors identified on the list below.

Electronic Prescribing Vendors

^{*THE DIVISION DOES NOT ENDORSE ANY PARTICULAR VENDOR, AND THE INFORMATION ON THIS RESOURCE SHEET MAY CHANGE AT ANY TIME.}